2. UroToday Home
  3. Available Urotoday Newsletters - Site Registration Required

GU Onc Daily

Bone Health in Advanced Prostate CancerSent on 14 December 2024
Emerging Therapeutics: Combination Therapy in Neoadjuvant Setting for Muscle-invasive Bladder Cancer Sent on 13 December 2024
UroAlert - GU Oncology DailySent on 13 December 2024
Practice-Changing Data in Metastatic Prostate Cancer Sent on 12 December 2024
UroAlert - GU Oncology DailySent on 12 December 2024
PSMA Imaging and Response Evaluation for Prostate CancerSent on 11 December 2024
UroAlert - GU Oncology DailySent on 11 December 2024
Treatments Targeting Resistance and Unlocking Immune Responses in Advanced Prostate Cancer Sent on 10 December 2024
UroAlert - GU Oncology DailySent on 10 December 2024
Clinical Progression of Prostate Cancer from Active Surveillance is Predicted by Decipher® Genomic Classifier Score on Index Biopsy & More from 2024 SUO Sent on 09 December 2024
UroAlert - GU Oncology DailySent on 09 December 2024
SUO 2024: Setting the Stage: Our Current Options for NMIBCSent on 06 December 2024
SUO 2024 Highlights: Advances in RCC, Testicular Cancer, NMIBC, and Emerging Therapies Sent on 06 December 2024
UroAlert - GU Oncology DailySent on 06 December 2024
CG Oncology Announces Bond-003 Topline ResultsSent on 05 December 2024
Society of Urologic Oncology (SUO) 2024: Exploring Advanced Disease, Adjuvant Therapy, and the Impact of Smoking CessationSent on 05 December 2024
UroAlert - GU Oncology DailySent on 05 December 2024
Society of Urologic Oncology (SUO) 2024 Advancements in Bladder Cancer TreatmentSent on 04 December 2024
Novel Treatment Approaches in Metastatic Castration-resistant Prostate CancerSent on 04 December 2024
UroAlert - GU Oncology DailySent on 04 December 2024
UroAlert - GU Oncology DailySent on 03 December 2024
UroAlert - GU Oncology DailySent on 02 December 2024
Reducing Bladder Cancer Recurrence: The Role of Improved Detection in Bladder CancerSent on 30 November 2024
Genomic Insights in Metastatic Hormone-Sensitive Prostate Cancer Sent on 29 November 2024
UroAlert - GU Oncology DailySent on 29 November 2024
UroAlert - GU Oncology DailySent on 28 November 2024
In Gratitude and Appreciation, A Message From UroToday!Sent on 27 November 2024
UroAlert - GU Oncology DailySent on 27 November 2024
New Horizons in the Treatment of Bladder CancerSent on 26 November 2024
UroAlert - GU Oncology DailySent on 26 November 2024
Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer TreatmentsSent on 25 November 2024
UroAlert - GU Oncology DailySent on 25 November 2024
Emerging Technologies to Advance Urologic Care in 2025 - LUGPA 2024 Annual Meeting PresentationsSent on 23 November 2024
Integrating New Technologies into Practice Management: LUGPA 2024 Annual EducationSent on 22 November 2024
UroAlert - GU Oncology DailySent on 22 November 2024
Precision Medicine at the Forefront of mCRPC TherapySent on 21 November 2024
UroAlert - GU Oncology DailySent on 21 November 2024
Innovative Therapies in GU CancersSent on 20 November 2024
UroAlert - GU Oncology DailySent on 20 November 2024
UroAlert - GU Oncology DailySent on 19 November 2024
Variant Histology Bladder Cancer Challenges and Future DirectionsSent on 18 November 2024
UroAlert - GU Oncology DailySent on 18 November 2024
Advances in Staging and Personalized Radiation TherapySent on 15 November 2024
UroAlert - GU Oncology DailySent on 15 November 2024
Risk Assessment and Treatment Intensification in Advanced Prostate CancerSent on 14 November 2024
UroAlert - GU Oncology DailySent on 14 November 2024
Reducing Financial Burdens and Advancing Personalized Prostate Cancer Care for VeteransSent on 13 November 2024
UroAlert - GU Oncology DailySent on 13 November 2024
Occupational and Environmental Risk Factors in Bladder CancerSent on 12 November 2024
UroAlert - GU Oncology DailySent on 12 November 2024
  • Page of 101
Display #
Results 1 - 50 out of 5018
Send the selected Newsletters to...